408,391 Shares in Revvity Inc. $RVTY Bought by Deutsche Bank AG

Deutsche Bank AG bought a new stake in Revvity Inc. (NYSE:RVTY) during the 2nd quarter, Holdings Channel reports. The institutional investor bought 408,391 shares of the company’s stock, valued at approximately $45,438,000.

A number of other institutional investors also recently bought and sold shares of the business. AQR Capital Management LLC boosted its position in shares of Revvity by 5.2% during the 1st quarter. AQR Capital Management LLC now owns 8,449 shares of the company’s stock worth $883,000 after acquiring an additional 420 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Revvity by 6.7% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,776 shares of the company’s stock worth $1,246,000 after purchasing an additional 744 shares during the last quarter. Millennium Management LLC boosted its holdings in Revvity by 102.0% in the first quarter. Millennium Management LLC now owns 69,401 shares of the company’s stock valued at $7,343,000 after purchasing an additional 35,048 shares in the last quarter. Goldman Sachs Group Inc. boosted its holdings in Revvity by 45.5% in the first quarter. Goldman Sachs Group Inc. now owns 607,104 shares of the company’s stock valued at $64,232,000 after purchasing an additional 189,871 shares in the last quarter. Finally, Focus Partners Wealth increased its stake in Revvity by 13.0% in the first quarter. Focus Partners Wealth now owns 7,028 shares of the company’s stock valued at $744,000 after purchasing an additional 811 shares during the last quarter. 86.65% of the stock is owned by hedge funds and other institutional investors.

Revvity Stock Performance

Shares of RVTY opened at $124.88 on Friday. The company’s 50 day simple moving average is $111.45 and its 200-day simple moving average is $100.37. The firm has a market cap of $13.93 billion, a PE ratio of 59.47, a price-to-earnings-growth ratio of 2.26 and a beta of 1.07. Revvity Inc. has a 12-month low of $81.22 and a 12-month high of $124.97. The company has a current ratio of 1.80, a quick ratio of 1.50 and a debt-to-equity ratio of 0.36.

Revvity (NYSE:RVTY) last released its quarterly earnings results on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, beating the consensus estimate of $1.21 by $0.20. The firm had revenue of $729.69 million during the quarter, compared to the consensus estimate of $702.96 million. Revvity had a net margin of 8.16% and a return on equity of 8.34%. Revvity’s revenue for the quarter was down 1.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.18 EPS. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. As a group, equities analysts predict that Revvity Inc. will post 5.36 EPS for the current year.

Revvity Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be issued a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 23rd. Revvity’s dividend payout ratio is presently 13.33%.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the stock. Robert W. Baird set a $117.00 price objective on shares of Revvity in a report on Wednesday, May 6th. JPMorgan Chase & Co. lowered their target price on shares of Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a report on Wednesday, May 6th. Wolfe Research started coverage on shares of Revvity in a research report on Tuesday, June 2nd. They issued a “peer perform” rating on the stock. Weiss Ratings upgraded shares of Revvity from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 30th. Finally, Zacks Research raised Revvity from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 4th. Three analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $108.36.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.